Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.571NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.571NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.571NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.55 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.55 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.55 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAMNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAMNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.239NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.239NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.239NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.574NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.574NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.574NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.355NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.355NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.355NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.7.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.403NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.403NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.367NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used